Associated Papers
Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor.
Rodrik-Outmezguine VS et al.
Nature, 2016
Transforming somatic mutations of mammalian target of rapamycin kinase in human cancer.
Yamaguchi H et al.
Cancer Science, 2015
26432419 (PubMed )
Supplement: CAS-106-00000000001687-s005.xlsx › Sheet1
Select a paper to view details